Teimori H, Akbari M T, Hamid M, Forouzandeh M, Bibordi E
Cellular and Molecular Research Center, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Genet Mol Res. 2011 Oct 7;10(4):2415-23. doi: 10.4238/2011.October.7.3.
Chromosomal abnormalities and ZAP70 expression profile are two major independent prognostic markers in B-cell chronic lymphocytic leukemia. We investigated a possible correlation between these two markers. ZAP70 expression using real-time RT-PCR was examined in 20 B-cell chronic lymphocytic leukemia patients with del13q14, 13 patients with del11q22, 15 patients with trisomy 12, and 16 patients with no detected chromosomal abnormalities. Molecular analysis revealed that ZAP70 expression in the del13q subgroup was the same as in the control group, while it increased 2.78-fold in the del11q subgroup and 2.95-fold in the trisomy 12 subgroup, compared to the 15 cases in the control group. Comparison of the mean and standard deviation of the ZAP70 expression profile within the subgroups showed it to be highly variable among the individuals of the del11q and trisomy 12 subgroups, versus tight clustering for the del13q subgroup. Therefore, there is a correlation between del13q aberration, which has good prognosis with normal levels of ZAP70 expression. Due to a high degree of variation, no conformity is seen for del11q and trisomy 12 subgroups, making this grouping poor for prognostic discrimination. As a result, neither of these markers can serve as sole discriminators to determine the course of the disease; the use of both markers improves prognostic assessment.
染色体异常和ZAP70表达谱是B细胞慢性淋巴细胞白血病的两个主要独立预后标志物。我们研究了这两个标志物之间可能存在的相关性。采用实时逆转录聚合酶链反应检测了20例伴有13q14缺失的B细胞慢性淋巴细胞白血病患者、13例伴有11q22缺失的患者、15例伴有12号染色体三体的患者以及16例未检测到染色体异常的患者的ZAP70表达。分子分析显示,与对照组的15例患者相比,13q14缺失亚组中的ZAP70表达与对照组相同,而在11q22缺失亚组中增加了2.78倍,在12号染色体三体亚组中增加了2.95倍。各亚组内ZAP70表达谱的均值和标准差比较显示,11q22缺失和12号染色体三体亚组个体间差异很大,而13q14缺失亚组个体间紧密聚集。因此,13q14缺失与ZAP70表达水平正常且预后良好之间存在相关性。由于差异程度高,11q22缺失和12号染色体三体亚组未见一致性,使得该分组对预后判别效果不佳。因此,这两个标志物都不能单独作为判别疾病进程的指标;同时使用这两个标志物可改善预后评估。